Jang, A., Kumar, H. L., Wu, C. W., Kyasaram, R. K., Sheng, I. Y. F., Mendiratta, P., Garcia, J. A., Barata, P. C., Rao, S., Brown, J. R. (2025). Impact of variant allele frequency (VAF) of TP53 alterations and Signatera circulating tumor DNA (ctDNA) monitoring for patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.830